Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Social Cognition in Psychiatric Disorders
NCT02149823Phase 1Terminated
- Start
- Sep 2013
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in borderline personality disorder (BPD), schizotypal personality disorder (STPD), Autism Spectrum Disorder (ASD) and 3 more (6 arms). Primary endpoint: Movie for the Assessment of Social Cognition at Day 57. Started Sep 2013; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
borderline personality disorder (BPD)schizotypal personality disorder (STPD)Autism Spectrum Disorder (ASD)schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02149823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149823.